{{Rsnum
|rsid=9468925
|Gene=WASF5P
|Chromosome=6
|position=31291060
|Orientation=plus
|GMAF=0.4518
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 45.1 | 39.8
| HCB | 17.5 | 43.1 | 39.4
| JPT | 32.4 | 49.5 | 18.0
| YRI | 37.4 | 51.7 | 10.9
| ASW | 26.3 | 45.6 | 28.1
| CHB | 17.5 | 43.1 | 39.4
| CHD | 10.2 | 39.8 | 50.0
| GIH | 12.9 | 54.5 | 32.7
| LWK | 23.9 | 54.1 | 22.0
| MEX | 15.8 | 49.1 | 35.1
| MKK | 5.1 | 42.9 | 51.9
| TSI | 13.7 | 54.9 | 31.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20526339
|Trait=Vitiligo
|Title=Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC
|RiskAllele=
|Pval=2E-33
|OR=1.35
|ORtxt=[1.28-1.41]
}}

{{omim
|id=193200
|rsnum=9468925
}}

{{PMID Auto
|PMID=21951294
|Title=A single nucleotide polymorphism rs9468925 of MHC region is associated with clinical features of generalized vitiligo in Chinese Han population
}}

{{PMID Auto
|PMID=20017995
|Title=A principal-components-based clustering method to identify multiple variants associated with rheumatoid arthritis and arthritis-related autoantibodies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}